Get the Stockscreener App
32.86
2.02%
0.65
After Hours:
32.21
-0.65
-1.98%
Newamsterdam Pharma Company Nv stock is traded at $32.86, with a volume of 672.40K.
It is up +2.02% in the last 24 hours and up +30.97% over the past month.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
See More
Previous Close:
$32.21
Open:
$32.61
24h Volume:
672.40K
Relative Volume:
0.77
Market Cap:
$3.70B
Revenue:
$14.09M
Net Income/Loss:
$-176.94M
P/E Ratio:
-15.28
EPS:
-2.15
Net Cash Flow:
$-141.24M
1W Performance:
+11.92%
1M Performance:
+30.97%
6M Performance:
+116.75%
1Y Performance:
+85.23%
1-Day Range:
$31.69
$33.28
1-Week Range:
$29.44
$34.62
52-Week Range:
$14.06
$34.62
Newamsterdam Pharma Company Nv Stock (NAMS) Company Profile
Name
Newamsterdam Pharma Company Nv
Sector
Industry
Phone
35 206 2971
Address
GOOIMEER 2-35, NARRDEN
Compare NAMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NAMS
Newamsterdam Pharma Company Nv
|
32.86 | 3.63B | 14.09M | -176.94M | -141.24M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Newamsterdam Pharma Company Nv Stock (NAMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-25-25 | Initiated | Wells Fargo | Overweight |
| Jul-17-25 | Initiated | Goldman | Neutral |
| Jun-17-25 | Initiated | Citigroup | Buy |
| Jun-10-25 | Initiated | Stifel | Buy |
| Jun-04-25 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-30-24 | Initiated | H.C. Wainwright | Buy |
| May-15-24 | Initiated | TD Cowen | Buy |
| Mar-14-24 | Initiated | Scotiabank | Sector Outperform |
| Jan-18-24 | Initiated | Guggenheim | Buy |
| Jan-16-24 | Initiated | Piper Sandler | Overweight |
| Oct-30-23 | Initiated | RBC Capital Mkts | Outperform |
View All
Newamsterdam Pharma Company Nv Stock (NAMS) Latest News
Knights of Columbus Asset Advisors LLC Invests $595,000 in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
NewAmsterdam Pharma Company N.V. (NAMS) Soars 5.9%: Is Further Upside Left in the Stock? - Yahoo Finance
NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Up 8.8%Here's Why - MarketBeat
Newamsterdam Pharma stock hits 52-week high at 31.96 USD By Investing.com - Investing.com Nigeria
NewAmsterdam Pharma Co. Hits New 52-Week High of USD 31.81 - Markets Mojo
Is NewAmsterdam Pharma Company NV a good long term investmentRSI Overbought/Oversold & Exceptional Profit Trading - earlytimes.in
Newamsterdam Pharma stock hits 52-week high at 31.96 USD - Investing.com India
Will NewAmsterdam Pharma Company N.V. (KH6) stock beat Nasdaq index returnsQuarterly Earnings Summary & Target Return Focused Stock Picks - newser.com
Institutional scanner results for NewAmsterdam Pharma Company N.V.Portfolio Risk Report & Entry Point Confirmation Alerts - newser.com
How NewAmsterdam Pharma Company N.V. stock performs in weak economyWeekly Stock Summary & Smart Money Movement Alerts - newser.com
Published on: 2025-10-05 03:30:23 - newser.com
NewAmsterdam Pharma Company N.V. Equity Warrant stock retracement – recovery analysisStock Surge & Real-Time Market Sentiment Alerts - newser.com
NewAmsterdam Pharma Co. NV Hits New 52-Week High at $29.66 - Markets Mojo
Exit strategy if you’re trapped in NewAmsterdam Pharma Company N.V.July 2025 Setups & Verified Technical Signals - newser.com
Can you recover from losses in NewAmsterdam Pharma Company N.V.Quarterly Performance Summary & Daily Market Momentum Tracking - newser.com
How NewAmsterdam Pharma Company N.V. (KH6) stock moves on employment dataJuly 2025 Volume & Free Technical Confirmation Trade Alerts - newser.com
Published on: 2025-10-02 23:50:02 - newser.com
Using data tools to time your NewAmsterdam Pharma Company N.V. exitEarnings Growth Report & Risk Adjusted Buy/Sell Alerts - newser.com
Why NewAmsterdam Pharma Company N.V. Equity Warrant stock attracts global investorsTrade Signal Summary & Growth Oriented Trading Recommendations - newser.com
Is NewAmsterdam Pharma Company N.V. stock reversal real or fakeJuly 2025 Trends & Stock Portfolio Risk Management - newser.com
NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results - ADVFN
NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results - ADVFN
NewAmsterdam Pharma (NASDAQ:NAMS) Reaches New 12-Month HighHere's What Happened - MarketBeat
Published on: 2025-10-01 08:11:23 - newser.com
NewAmsterdam Pharma Stock Hits Day High with 8.41% Surge - Markets Mojo
NewAmsterdam Pharma Soars 9.15% to Hit Intraday High of $26.75 - Markets Mojo
What drives NewAmsterdam Pharma Company NV Equity Warrant stock price - earlytimes.in
Is this a good reentry point in NewAmsterdam Pharma Company N.V.2025 Biggest Moves & AI Driven Stock Reports - newser.com
NewAmsterdam Pharma Co. NV Hits New 52-Week High of $28.61 - Markets Mojo
Is Vakrangee Limited Stock Risky in the Current Market EnvironmentPrice Support Zones & Low Cost Wealth Investment - earlytimes.in
What analysts say about NewAmsterdam Pharma Company NV KH6 stockMorning Star Patterns & Invest Now – Opportunity Window Closing - earlytimes.in
NewAmsterdam Pharma Company NV KH6 Stock Analysis and ForecastSupport and Resistance Levels & Low Entry Investment Portfolio - earlytimes.in
Top chart patterns to watch in NewAmsterdam Pharma Company N.V. Equity Warrant2025 Price Momentum & Expert Approved Trade Ideas - newser.com
What drives NewAmsterdam Pharma Company NV KH6 stock priceInstitutional Holding Changes & Affordable Growth Investments - Early Times
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
NewAmsterdam Pharma (NASDAQ:NAMS) Sets New 1-Year HighHere's What Happened - MarketBeat
Newamsterdam Pharma stock hits 52-week high at 27.4 USD By Investing.com - Investing.com Canada
Newamsterdam Pharma stock hits 52-week high at 27.4 USD - Investing.com
What analysts say about NewAmsterdam Pharma Company NV stockFibonacci Retracement Levels & Free Daily Investment Newsletter Subscription - Early Times
NewAmsterdam Pharma to Present at the Stifel 2025 Virtual Cardiometabolic Forum - GlobeNewswire
Non-Statin Medicine Developer NewAmsterdam Pharma to Present Latest CVD Research at Stifel Forum - Stock Titan
Newamsterdam Pharma Company Nv Stock (NAMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Newamsterdam Pharma Company Nv Stock (NAMS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Kooij Louise Frederika | Chief Accounting Officer |
Sep 09 '25 |
Option Exercise |
10.00 |
150,000 |
1,500,000 |
165,000 |
| Kooij Louise Frederika | Chief Accounting Officer |
Sep 09 '25 |
Sale |
25.83 |
150,000 |
3,874,017 |
15,000 |
| Topper James N | Director |
Sep 08 '25 |
Buy |
24.99 |
1,260 |
31,487 |
3,027,864 |
2.05%
4.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):